Details for Patent: 7,407,943
✉ Email this page to a colleague
Summary for Patent: 7,407,943
| Title: | Antisense modulation of apolipoprotein B expression |
| Abstract: | Antisense compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for treatment of diseases associated with expression of apolipoprotein B are provided. |
| Inventor(s): | Crooke; Rosanne M. (Carlsbad, CA), Graham; Mark J. (San Clemente, CA) |
| Assignee: | ISIS Pharmaceuticals, Inc. (Carlsbad, CA) |
| Application Number: | 10/147,196 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 7,407,943
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,407,943
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2002326481 | ⤷ Sign Up | |||
| Australia | 2003237875 | ⤷ Sign Up | |||
| Australia | 2003294281 | ⤷ Sign Up | |||
| Canada | 2455228 | ⤷ Sign Up | |||
| Canada | 2505801 | ⤷ Sign Up | |||
| Cyprus | 1114168 | ⤷ Sign Up | |||
| Cyprus | 1114199 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
